US8101198B2ActiveUtilityA1
Osteogenic enhancer composition
Est. expiryJul 26, 2026(~0 yrs left)· nominal 20-yr term from priority
A61P 43/00A61K 38/00A61K 45/06A61K 31/197A61L 2300/41A61L 2430/02A61L 2300/64A61L 2300/414A61L 2300/43A61L 2300/428A61L 2300/112A61P 19/00A61K 35/32A61K 31/573A61L 24/0015A61L 27/54
69
PatentIndex Score
1
Cited by
48
References
11
Claims
Abstract
An osteogenic enhancer composition for bone and cartilage repair and methods of using the same are described.
Claims
exact text as granted — not AI-modified1. A composition comprising N-acetyl cysteine (NAC) in an amount effective for enhancing osteoblastic differentiation and a material selected from the group consisting of a collagen gel, collagen sponge, collage membrane, demineralized bone matrix, bone cement, and a cement or scaffold for bone, cartilage or vertebra, wherein the composition is effective for bone or cartilage repair.
2. The composition of claim 1 , further comprising a methacrylate or acrylate based prepolymer.
3. The composition of claim 1 , further comprising a biodegradable polymer.
4. The composition of claim 3 , wherein the biodegradable polymer is poly(lactic acid), poly(lactic-co-glycolic acid) (PLGA), poly(hydroxyalkanoate), or polymers or copolymers of a lactone.
5. The composition of claim 1 , further comprising a non-degradable polymer.
6. The composition of claim 1 , further comprising a bioactive agent selected from an adhesion molecule, a bone growth factor, a transforming growth factor (TGF), a transcription factor, fibroblast growth factor (FGF), an insulin like growth factor (IGF), a vascular endothelial growth factor (VEGF), a hormone, an anti-inflammatory agent, calcium phosphate, vitamin, an osteogenic cell, an osteoblastic cell, or combinations thereof
7. The composition of claim 6 , wherein the anti-inflammatory agent is selected from steroidal or non-steroidal anti-inflammatory agents, glucocorticoids, or combinations thereof
8. The composition of claim 6 , wherein the anti-inflammatory agent is selected from dexamethasone, betamethasone, cortisone, or combinations thereof.
9. The composition of claim 1 , further comprising a pharmaceutically acceptable carrier.
10. The composition of claim 1 , wherein the material is a cement or scaffold for bone, cartilage or vertebra.
11. The composition of claim 1 , wherein the material is collagen gel, collagen sponge, collagen membrane or bone cement.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.